Noteworthy OKTA Put and Call Options Set for December 19th
Put Contract Analysis: The $85.00 put contract for OKTA has a bid of $5.65, allowing investors to potentially buy shares at a cost basis of $79.35, which is attractive compared to the current price of $86.90. There is a 60% chance the contract may expire worthless, offering a potential 6.65% return on cash commitment.
Call Contract Strategy: The $90.00 call contract has a bid of $6.00, allowing investors to sell shares at that price if they buy at $86.90. This could yield a 10.47% return if exercised, with a 50% chance of expiring worthless, which would still provide a 6.90% additional return.
Volatility Insights: The implied volatility for the put contract is 53% and for the call contract is 52%, while the actual trailing twelve-month volatility is calculated at 46%.
YieldBoost Concept: Both the put and call contracts offer potential YieldBoosts, with the put providing a 38.49% annualized return if it expires worthless, and the call offering a 39.98% annualized return under similar conditions.
Trade with 70% Backtested Accuracy
Analyst Views on OKTA
About OKTA
About the author

- Dow Hits All-Time High: The Dow Jones Industrial Average rose by 0.64%, reaching a new all-time high, reflecting investor confidence in economic recovery, despite mixed overall market performance indicating divergent views among investors on various sectors.
- Chip Stocks Decline: With Marvell Technology and Intel falling over 9% and 8% respectively, the weakness in chipmakers weighed on the broader market, suggesting that the pressure on tech stocks may impact future investment sentiment.
- Weak Housing Data: U.S. May housing starts fell 15.4% month-over-month to a six-year low of 1.177 million, below expectations of 1.430 million, indicating that the weakness in the housing market could pose challenges to economic growth.
- Oil Prices Plummet: WTI crude oil prices dropped more than 5% to a 3.5-month low due to the U.S.-Iran agreement to reopen the Strait of Hormuz, enhancing expectations for a revival in oil supplies, which may affect the performance of energy stocks.
- Market Divergence: The S&P 500 Index fell by 0.18% and the Nasdaq 100 Index dropped by 0.83%, while the Dow Jones Industrial Average rose by 0.69% to a new all-time high, indicating a divergence in market performance, particularly as energy stocks are pressured by plunging crude oil prices.
- Weak Housing Data: US May housing starts fell by 15.4% month-over-month to a six-year low of 1.177 million, significantly below the expected 1.430 million, while building permits also declined slightly, reflecting weakness in the real estate market that could negatively impact overall economic growth.
- Oil Price Impact on Sentiment: WTI crude oil prices dropped over 3% to a 3.25-month low due to the US-Iran agreement to reopen the Strait of Hormuz, which has eased inflation expectations; while this provides short-term support for stocks, the long-term effects remain to be seen.
- Fed Meeting Focus: The market is turning its attention to the two-day FOMC meeting, where rates are expected to remain unchanged, but the press conference led by new Chair Kevin Warsh will be crucial, as investors will look for insights on future inflation outlook and policy direction.
- IPO Fundraising Scale: SpaceX plans to issue 555,555,555 shares at $135 each, aiming to raise $75 billion and achieve a valuation of $1.77 trillion, setting a historic record that reflects strong market confidence in its growth potential.
- Business Diversification: The company operates in three segments: rocket launches, satellite internet, and artificial intelligence, with the rocket launch segment having successfully launched approximately 650 times at a 99% success rate, solidifying its leadership in the aerospace market.
- Strategic Partnership Agreement: SpaceX has reached a deal with Alphabet to receive $920 million per month for computing capacity from 2026 to 2029, valued at $30 billion, which will significantly enhance the company's financial position and market competitiveness.
- Investment Risk Warning: Despite the optimistic IPO outlook, historical data shows that over half of the 30 largest IPOs in the past 15 years saw stock prices decline within the first week and at 12 months, indicating that investors should approach newly listed stocks with caution due to their volatility.
- Massive Fundraising: SpaceX plans to offer 555,555,555 shares at $135 each, aiming to raise $75 billion and achieve a valuation of $1.77 trillion, setting a historical record that reflects strong market confidence in its growth prospects.
- Diverse Business Segments: SpaceX operates in rocket launches, satellite internet, and artificial intelligence, with a notable 99% success rate in rocket launches and a network of approximately 9,600 Starlink satellites, enhancing its competitive edge globally.
- Intriguing Financials: In 2025, SpaceX generated $18.7 billion in revenue, a 33% year-over-year increase, but reported a net loss of $4.9 billion; however, an adjusted EBITDA of $6.6 billion indicates potential profitability, and a $30 billion deal with Alphabet will further improve its financial position.
- Investment Risk Advisory: Historical data shows that over half of the 30 largest IPOs in the past 15 years performed poorly in their first year, prompting investors to exercise caution, especially since founder Elon Musk will control 82% of the voting power, limiting retail investors' influence on company decisions.
- Tech Stock Decline: Broadcom (AVGO) shares plummeted over 15% after its AI revenue forecast fell short, marking it as the largest decliner in the Nasdaq 100, which reflects growing concerns about the tech sector and may dampen investor confidence.
- Weak Employment Data: Initial jobless claims in the US rose by 13,000 to 225,000, reaching a 3.75-month high, indicating a weakening labor market that could lead to downward revisions in growth expectations.
- Healthcare Stocks Strong: UnitedHealth Group (UNH) surged over 6%, leading gains in the S&P 500, after Bank of America upgraded its rating from neutral to buy with a price target of $450, showcasing resilience in the healthcare sector.
- International Market Volatility: European markets showed mixed results, with Eurozone April retail sales falling 0.4% month-over-month, worse than the expected 0.3%, indicating weak consumer spending that could pressure future economic growth.
- Market Retreat: On Wednesday, the S&P 500 index fell by 0.74%, the Dow Jones Industrial Average dropped by 1.21%, and the Nasdaq 100 index decreased by 0.29%, indicating market vulnerability amid escalating US-Iran tensions that negatively impacted investor sentiment.
- Oil Price Surge: WTI crude oil prices rose over 2% to a 1.5-week high following the US interception of Iranian missiles and drones, heightening concerns about Middle Eastern stability and potentially affecting global supply chains and inflation expectations.
- Strong Employment Data: The US May ADP employment change increased by 122,000, surpassing expectations of 120,000, signaling signs of economic recovery that could support the stock market, although overall market performance remains influenced by other factors.
- Divergent Tech Stock Performance: While Marvell Technology rose over 3%, software and cybersecurity stocks faced significant declines, with Datadog and IBM dropping more than 6%, reflecting a lack of confidence in the tech sector despite some positive developments.











